Global Pneumonia Vaccines Market to reach a market size of $9.6 billion by 2025- KBV Research

Global Pneumonia Vaccines Market to reach a market size of $9.6 billion by 2025- KBV Research

Global Pneumonia Vaccines Market to reach a market size of $9.6 billion by 2025- KBV Research

Salud

According to a new report Global Pneumonia Vaccines Market, published by KBV research, The Global Pneumonia Vaccines Market size is expected to reach $9.6 billion by 2025, rising at a market growth of 5.1% CAGR during the forecast period.



The North America market dominated the Global Pneumococcal Conjugate Vaccine (PCV) Market by Region in 2018, growing at a CAGR of 2.8 % during the forecast period. The Europe market is expected to witness a CAGR of 3.6% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 5.3% during (2019-2025).



The Prevnar 13 market dominated the Global Pneumonia Vaccines Market by Product Type in 2018, growing at a CAGR of 4.1 % during the forecast period. The Synflorix market is expected to witness a CAGR of 7.5% during (2019-2025). Additionally, The Pneumovax23 market is expected to witness highest CAGR of 8.5% during (2019-2025).



The Distribution Partner Companies market dominated the Global Pneumonia Vaccines Market by Distribution Channel in 2018, growing at a CAGR of 4.3 % during the forecast period. The Non-Governmental Organizations (NGO) market is expected to witness a CAGR of 6% during (2019-2025).



Full Report: https://www.kbvresearch.com/pneumonia-vaccines-market/



The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Glaxosmithkline Plc. (GSK), LG Corporation, Panacea Biotec Limited, Pfizer, Inc., Pnuvax Incorporated, Poonawalla Investments & Industries Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Holdings Co., Ltd., Walvax Biotechnology Co., Ltd. and MERCK & CO., Inc.



Global Pneumonia Vaccines Market Segmentation



By Vaccine Type



Pneumococcal conjugate vaccine (PCV)



Pneumococcal polysaccharide vaccine (PPSV/PPV)



By Product Type



Prevnar 13



Synflorix



Pneumovax23



By Sector



Public sector



Private sector



By Distribution Channel



Distribution partner companies



Non-governmental Organizations (NGO)



Government Authorities



By Geography



North America



US



Canada



Mexico



Rest of North America



Europe



Germany



UK



France



Russia



Spain



Italy



Rest of Europe



Asia Pacific



China



Japan



India



South Korea



Singapore



Malaysia



Rest of Asia Pacific



LAMEA



Brazil



Argentina



UAE



Saudi Arabia



South Africa



Nigeria



Rest of LAMEA



Companies Profiled



Glaxosmithkline Plc. (GSK)



LG Corporation



Panacea Biotec Limited



Pfizer, Inc.



Pnuvax Incorporated



Poonawalla Investments & Industries Pvt. Ltd.



Shenzhen Kangtai Biological Products Co., Ltd.



SK Holdings Co., Ltd.



Walvax Biotechnology Co., Ltd.



Merck & Co., Inc.



Pneumonia Vaccines Market Related Reports:



North America Market



Europe Market



Asia Pacific Market



LAMEA Market



 

KBV ResearchGlobal Pneumonia Vaccines Market to reach a market size of $9.6 billion by 2025- KBV Research
posicionamiento en buscadores
Vive Sex Shop - Tienda online de Juguetes eróticos